Health
Second study testing Covid-19 antibody drug has a setback – Deccan Herald
For the second time, a study testing an experimental antibody drug for Covid-19 has been paused to investigate a possible safety issue in hospitalised patients….
For the second time, a study testing an experimental antibody drug for Covid-19 has been paused to investigate a possible safety issue in hospitalised patients.
Regeneron Pharmaceuticals Inc. said Friday that independent monitors had recommended placing on hold enrollment of the most severely ill patients — those who need intense oxygen treatment or breathing machines — because of a potential safety problem and unfavourable balance of risks and benefits.
The study can continue to test the two-antibody…
Continue Reading
